BIOMAT Database Logo BIOMAT Database Logo

The effect of intravenous L-dopa on growth hormone and luteinizing hormone levels in man. 1973

A Souvatzoglou, and K von Werder, and P Bottermann

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

A Souvatzoglou, and K von Werder, and P Bottermann
Effect of intravenous infusion of L-DOPA on plasma growth hormone levels in man.
January 1973, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
A Souvatzoglou, and K von Werder, and P Bottermann
Effect of L-dopa on testosterone and luteinizing hormone production.
April 1972, The Journal of clinical endocrinology and metabolism,
A Souvatzoglou, and K von Werder, and P Bottermann
Effect of chronic L-dopa administration on serum luteinizing hormone levels in male rats.
March 1995, Toxicology,
A Souvatzoglou, and K von Werder, and P Bottermann
Suppressive effect of cyproheptadine on L-DOPA-induced growth hormone release in man.
August 1975, Endocrinologia japonica,
A Souvatzoglou, and K von Werder, and P Bottermann
Release of human growth hormone, follicle stimulating hormone, and luteinizing hormone in response to L-dihydroxy-phenylalanine (L-dopa) in normal man.
December 1972, Diseases of the nervous system,
A Souvatzoglou, and K von Werder, and P Bottermann
The effect of L-dopa and clomiphene citrate on peripheral plasma levels of luteinizing hormone-releasing factor.
July 1976, Obstetrics and gynecology,
A Souvatzoglou, and K von Werder, and P Bottermann
Inhibitory effect of cimetidine on L-dopa-stimulated growth hormone release in normal man.
November 1984, Clinical endocrinology,
A Souvatzoglou, and K von Werder, and P Bottermann
Effect of L-dopa on anterior pituitary hormone release in man.
October 1972, Endocrinologia japonica,
A Souvatzoglou, and K von Werder, and P Bottermann
Effect of sulpiride on serum growth hormone and prolactin concentrations following L-DOPA administration in man.
April 1977, Endocrinologia japonica,
A Souvatzoglou, and K von Werder, and P Bottermann
Comparison of the effect of apomorphine and L-DOPA on serum growth hormone levels in normal men.
May 1975, Clinical endocrinology,
Copied contents to your clipboard!